HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Dezocine for Preventing Postoperative Pain: A Meta-Analysis of Randomized Controlled Trials.

AbstractBACKGROUND:
Dezocine is considered to be an alternative medication for managing postoperative pain. The aim of this study was to assess the efficacy and safety of this drug in this regard.
METHODS:
Medline, EMBASE and the Cochrane Central Register of Control Trials (CENTRAL) were searched to identify all randomized controlled trials (RCTs) that compare dezocine with placebo or dezocine with morphine on postoperative pain. The data were extracted and pooled using Mantel-Haenszel random effects model. Heterogeneity was tested using the I2 statistic with values >50% and Chi2 test with P ≤ 0.05 indicating obvious heterogeneity between the studies.
RESULTS:
Seven trials evaluating 665 patients were included. The number of patients with at least 50% pain relief was increased (N = 234; RR 3.04, 95% CI 2.27 to 4.08) and physician (N = 465; RR 2.84, 95% CI 1.66 to 4.84) and patient satisfaction (N = 390; RR 2.81, 95% CI 1.85 to 4.26) were improved following the administration of dezocine compared with the placebo. The effects of dezocine were similar to those of morphine in terms of the number of patients reporting at least 50% pain relief within 2-6 h after surgery (N = 235; RR 1.29, 95% CI 1.15 to 1.46) and physician (N = 234; RR 1.18, 95% CI 0.93 to 1.49) and patient (N = 158; RR 1.33, 95% CI 0.93 to 1.92) satisfaction. While, the number of patients with at least 50% pain relief within 0-1 h after surgery increased following dezocine compared with morphine treatment (N = 79; RR 1.45, 95% CI 1.18 to 1.77). There was no difference in the incidence of postoperative nausea and vomiting (PONV) following dezocine treatment compared with the placebo (N = 391; RR 1.06, 95% CI 0.42 to 2.68) or morphine treatment (N = 235; RR 0.65, 95% CI 0.14 to 2.93).
CONCLUSION:
Dezocine is a promising analgesic for preventing postoperative pain, but further studies are required to evaluate its safety.
AuthorsXuelong Zhou, Chenjing Zhang, Min Wang, LiNa Yu, M Yan
JournalPloS one (PLoS One) Vol. 10 Issue 8 Pg. e0136091 ( 2015) ISSN: 1932-6203 [Electronic] United States
PMID26287536 (Publication Type: Journal Article, Meta-Analysis)
Chemical References
  • Analgesics, Opioid
  • Bridged Bicyclo Compounds, Heterocyclic
  • Tetrahydronaphthalenes
  • Morphine
  • dezocine
Topics
  • Analgesics, Opioid (adverse effects, pharmacology)
  • Bridged Bicyclo Compounds, Heterocyclic (adverse effects, pharmacology)
  • Humans
  • Morphine (adverse effects, pharmacology)
  • Pain Management (methods)
  • Pain, Postoperative (prevention & control)
  • Patient Satisfaction
  • Randomized Controlled Trials as Topic
  • Tetrahydronaphthalenes (adverse effects, pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: